2014
DOI: 10.1590/1519-6984.13212
|View full text |Cite
|
Sign up to set email alerts
|

Cytogenetics analyses among populations of the fish Iheringichtys labrosus (Kröyer, 1874) (Siluriformes, Pimelodidae). Karyotype analysis, C- banding and AgRONs distribution

Abstract: Karyotypic data on Iheringichthys labrosus from several populations of Paraná River/Argentina are presented. The diploid number was 2n=56 and the karyotype consisted of 42m/sm + 14st/a (NF= 98). The AgNORs were observed in telomeres of the long arm of a st/a chromosome pair. These sites were also positive after C-banding. Heterochromatin was observed in the telomeric position in some chromosomal pairs and can be found in one or both metacentric chromosome arms. The obtained results were compared with those rep… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…However, there has been a considerable reduction in mortality owing to such hematological malignancies (Prakash et al, 2016;Siegel et al, 2011). Generally, this positive development is due to robust diagnostic approaches over the last decade or so, primarily due to genetic advancement in the area of hemato-oncology and its application (Prakash et al, 2016;Sánchez et al, 2014). Cytogenetic testing also includes diagnostic tools and vital knowledge of malignancies for hemato-oncologists, helping physicians to determine the patients' prognosis, diagnosis, and effective anti-cancer treatment and monitor their response.…”
Section: Introductionmentioning
confidence: 99%
“…However, there has been a considerable reduction in mortality owing to such hematological malignancies (Prakash et al, 2016;Siegel et al, 2011). Generally, this positive development is due to robust diagnostic approaches over the last decade or so, primarily due to genetic advancement in the area of hemato-oncology and its application (Prakash et al, 2016;Sánchez et al, 2014). Cytogenetic testing also includes diagnostic tools and vital knowledge of malignancies for hemato-oncologists, helping physicians to determine the patients' prognosis, diagnosis, and effective anti-cancer treatment and monitor their response.…”
Section: Introductionmentioning
confidence: 99%